Login

Verisec's Freja Emerges as Top Choice for UK Public Sector Identity Management | Johan Henrikson , CEO & Co-founder at Verisec AB 00:10:00

Share On Facebook Share On Twitter

Johan Henrikson is the CEO & Co-founder at Verisec AB

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
We are passionate customer-centric enablers. We empower our customers to deliver high performance through our unique end-to-end value proposition|Alain Conrard,CEO,Prodware SA
00:10:00
Portofino Resources' Lithium Exploration Journey in Argentina: Insights from the One-to-One Conference
00:00:00
Priya Sampathkumar, M.D. Critical Care Specialist, Mayo Clinic
00:10:00
Empowering Heirs: Preparing for Wealth Transfer with Eric Lawton - Eric Lawton | Wealth Advisor | Impact Financial Wealth Management, LLC
00:10:00
VC fund firm focused exclusively on funding entrepreneurs with a vision|Michael Staton,Venture Partner,Learn Capital
00:10:00
China's Steel Market Dynamics and Iron Ore Supply
00:10:00
Backs bold entrepreneurs building the future through technology|Martin Casado,General Partner,Andreessen Horowitz
00:10:00
Galan Lithium: Pioneering Lithium Chloride Production in Argentina
00:10:00
UTI AMC's 2009 Milestones: Exam Opening, Subscriber Growth, and Key Industry Insights | Imtaiyazur Rahman , CEO , UTI Asset Management.
00:10:00
Technology entrepreneur, investor, & future forward optimist|Elad Gil,Angel Investor
00:10:00
Nicholas Vickery on Patriot Lithium’s Latest Pegmatite Corridor Discovery in Black Hills | Nick Vickery ,CEO , Patriot Lithium Ltd.
00:10:00
CEO Stefan Eriksson and CFO Mats Almgren on Past Achievements and Future Plans | Stefan Eriksson, CEO, Tura Group AB.

© 2017 - Neuhu+